Skip to main content

Advertisement

SpringerLink
Log in

Penile Cancer: Managing Sexual Dysfunction and Improving Quality of Life After Therapy

  • Men's Health (R Carrion, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To review the most current literature on how the treatment for penile cancer can affect quality of life and to discuss current treatment options to overcome sexual dysfunction and ultimately improve patient wellbeing.

Recent Findings

Multiple medical and surgical therapies exist to address the high incidence of sexual dysfunction following penile cancer treatment. Advancements and refinements in the neophalloplasty, penile prosthesis, and penile lengthening procedures have opened the door to improved long-term outcomes. Additionally, studies continue to highlight the severe psychological toll that penile cancer treatment can have on patients. We explore the potential options for addressing the inherent psychologic effects of these treatments and highlight the need for further research in this domain.

Summary

Although rare, it is important for all urologists to be familiar with the treatments and post-treatment sequelae of penile cancer. Penile cancer is associated with dramatic decline in quality of life and sexual function. Multiple medical and surgical therapies exist that addresses these concerns. Additionally, urologists must also be mindful of the psychologic component regarding surgical disfigurement and the decline in sexual function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. https://doi.org/10.3322/caac.21590.

    Article  PubMed  Google Scholar 

  2. Douglawi A, Masterson TA. Penile cancer epidemiology and risk factors: a contemporary review. Curr Opin Urol. 2019;29(2):145–9. https://doi.org/10.1097/mou.0000000000000581.

    Article  PubMed  Google Scholar 

  3. Koifman L, Vides AJ, Koifman N, Carvalho JP, Ornellas AA. Epidemiological aspects of penile cancer in Rio de Janeiro: evaluation of 230 cases. Int Braz J Urol. 2011;37(2):231–40; discussion 40-3. https://doi.org/10.1590/s1677-55382011000200010.

    Article  PubMed  Google Scholar 

  4. Marchioni M, Berardinelli F, De Nunzio C, Spiess P, Porpiglia F, Schips L, et al. New insight in penile cancer. Minerva Urol Nefrol. 2018;70(6):559–69. https://doi.org/10.23736/s0393-2249.18.03215-0.

    Article  PubMed  Google Scholar 

  5. Pow-Sang MR, Ferreira U, Pow-Sang JM, Nardi AC, Destefano V. Epidemiology and natural history of penile cancer. Urology. 2010;76(2 Suppl 1):S2–6. https://doi.org/10.1016/j.urology.2010.03.003.

    Article  PubMed  Google Scholar 

  6. Olesen TB, Sand FL, Rasmussen CL, Albieri V, Toft BG, Norrild B, et al. Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 2019;20(1):145–58. https://doi.org/10.1016/s1470-2045(18)30682-x.

  7. Alemany L, Cubilla A, Halec G, Kasamatsu E, Quiros B, Masferrer E, et al. Role of human papillomavirus in penile carcinomas worldwide. Eur Urol. 2016;69(5):953–61. https://doi.org/10.1016/j.eururo.2015.12.007.

    Article  PubMed  Google Scholar 

  8. Kidd LC, Chaing S, Chipollini J, Giuliano AR, Spiess PE, Sharma P. Relationship between human papillomavirus and penile cancer-implications for prevention and treatment. Transl Androl Urol. 2017;6(5):791–802. https://doi.org/10.21037/tau.2017.06.27.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (London, England). 2007;370(9581):59–67. https://doi.org/10.1016/s0140-6736(07)61050-2.

    Article  Google Scholar 

  10. Maden C, Sherman KJ, Beckmann AM, Hislop TG, Teh CZ, Ashley RL, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993;85(1):19–24. https://doi.org/10.1093/jnci/85.1.19.

  11. Morris BJ, Gray RH, Castellsague X, Bosch FX, Halperin DT, Waskett JH, et al. The strong protective effect of circumcision against cancer of the penis. Adv Urol. 2011;2011:812368–21. https://doi.org/10.1155/2011/812368.

  12. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116(4):606–16. https://doi.org/10.1002/ijc.21009.

  13. Hellberg D, Valentin J, Eklund T, Nilsson S. Penile cancer: is there an epidemiological role for smoking and sexual behaviour? Br Med J (Clin Res Ed). 1987;295(6609):1306–8. https://doi.org/10.1136/bmj.295.6609.1306.

    Article  CAS  Google Scholar 

  14. Harish K, Ravi R. The role of tobacco in penile carcinoma. Br J Urol. 1995;75(3):375–7. https://doi.org/10.1111/j.1464-410x.1995.tb07352.x.

    Article  CAS  PubMed  Google Scholar 

  15. Micali G, Nasca MR, Innocenzi D. Lichen sclerosus of the glans is significantly associated with penile carcinoma. Sexually Transmitted Infections. 2001;77(3):226. https://doi.org/10.1136/sti.77.3.226.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Barocas DA, Chang SS. Penile cancer: clinical presentation, diagnosis, and staging. Urol Clin North Am. 2010;37(3):343–52. https://doi.org/10.1016/j.ucl.2010.04.002.

    Article  PubMed  Google Scholar 

  17. Kayes O, Minhas S, Allen C, Hare C, Freeman A, Ralph D. The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol. 2007;51(5):1313–8; discussion 8-9. https://doi.org/10.1016/j.eururo.2006.11.014.

    Article  PubMed  Google Scholar 

  18. Network NCC. Penile cancer (Version 1.2020). https://www.nccn.org/professionals/physician_gls/pdf/penile_blocks.pdf. Accessed April 12, 2020.

  19. Leone A, Diorio GJ, Pettaway C, Master V, Spiess PE. Contemporary management of patients with penile cancer and lymph node metastasis. Nat Rev Urol. 2017;14(6):335–47. https://doi.org/10.1038/nrurol.2017.47.

    Article  PubMed  Google Scholar 

  20. Diorio GJ, Leone AR, Spiess PE. Management of penile cancer. Urology. 2016;96:15–21. https://doi.org/10.1016/j.urology.2015.12.041.

    Article  PubMed  Google Scholar 

  21. O'Brien JS, Perera M, Manning T, Bozin M, Cabarkapa S, Chen E, et al. Penile cancer: contemporary lymph node management. J Urol. 2017;197(6):1387–95. https://doi.org/10.1016/j.juro.2017.01.059.

  22. Alnajjar HM, Lam W, Bolgeri M, Rees RW, Perry MJ, Watkin NA. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol. 2012;62(5):923–8. https://doi.org/10.1016/j.eururo.2012.02.052.

    Article  CAS  PubMed  Google Scholar 

  23. Baumgarten AS, Fisher JS, Lawindy SM, Pavlinec JG, Carrion RE, Spiess PE. Penile sparing surgical approaches for primary penile tumors: preserving function and appearance. Transl Androl Urol. 2017;6(5):809–19. https://doi.org/10.21037/tau.2017.04.01.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bandieramonte G, Colecchia M, Mariani L, Lo Vullo S, Pizzocaro G, Piva L, et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol. 2008;54(4):875–82. https://doi.org/10.1016/j.eururo.2008.01.019.

  25. Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term followup. J Urol. 2003;169(6):2118–21. https://doi.org/10.1097/01.ju.0000067361.81295.a2.

    Article  PubMed  Google Scholar 

  26. Tang DH, Yan S, Ottenhof SR, Draeger D, Baumgarten AS, Chipollini J, et al. Laser ablation as monotherapy for penile squamous cell carcinoma: a multi-center cohort analysis. Urol Oncol. 2018;36(4):147–52. https://doi.org/10.1016/j.urolonc.2017.09.028.

  27. Chipollini J, Yan S, Ottenhof SR, Zhu Y, Draeger D, Baumgarten AS, et al. Surgical management of penile carcinoma in situ: results from an international collaborative study and review of the literature. BJU Int. 2018;121(3):393–8. https://doi.org/10.1111/bju.14037.

  28. Raskin Y, Vanthoor J, Milenkovic U, Muneer A, Albersen M. Organ-sparing surgical and nonsurgical modalities in primary penile cancer treatment. Curr Opin Urol. 2019;29(2):156–64. https://doi.org/10.1097/mou.0000000000000587.

    Article  PubMed  Google Scholar 

  29. Minhas S, Kayes O, Hegarty P, Kumar P, Freeman A, Ralph D. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96(7):1040–3. https://doi.org/10.1111/j.1464-410X.2005.05769.x.

    Article  PubMed  Google Scholar 

  30. Kamel MH, Bissada N, Warford R, Farias J, Davis R. Organ sparing surgery for penile cancer: a systematic review. J Urol. 2017;198(4):770–9. https://doi.org/10.1016/j.juro.2017.01.088.

    Article  PubMed  Google Scholar 

  31. Kamel MH, Tao J, Su J, Khalil MI, Bissada NK, Schurhamer B, et al. Survival outcomes of organ sparing surgery, partial penectomy, and total penectomy in pathological T1/T2 penile cancer: report from the National Cancer Data Base. Urologic Oncol. 2018;36(2):82.e7-.e15. https://doi.org/10.1016/j.urolonc.2017.10.017.

    Article  Google Scholar 

  32. Lindner AK, Schachtner G, Steiner E, Kroiss A, Uprimny C, Steinkohl F, et al. Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival. World J Urol. 2020;38(2):417–24. https://doi.org/10.1007/s00345-019-02793-9.

  33. Baumgarten A, Chipollini J, Yan S, Ottenhof SR, Tang DH, Draeger D, et al. Penile sparing surgery for penile cancer: a multicenter international retrospective cohort. J Urol. 2018;199(5):1233–7. https://doi.org/10.1016/j.juro.2017.10.045.

  34. Shindel AW, Mann MW, Lev RY, Sengelmann R, Petersen J, Hruza GJ, et al. Mohs micrographic surgery for penile cancer: management and long-term followup. J Urol. 2007;178(5):1980–5. https://doi.org/10.1016/j.juro.2007.07.039.

  35. Fenner A. Penile cancer: total glans resurfacing viable for all. Nat Rev Urol. 2017;14(4):198. https://doi.org/10.1038/nrurol.2017.7.

    Article  PubMed  Google Scholar 

  36. Tang DH, Yan S, Ottenhof SR, Draeger D, Baumgarten AS, Chipollini J, et al. Glansectomy as primary management of penile squamous cell carcinoma: an international study collaboration. Urology. 2017;109:140–4. https://doi.org/10.1016/j.urology.2017.08.004.

  37. Hakenberg OW, Minhas ES, Necchi A, Protzel C, Watkin N, Compérat E, et al. European Association of Urology guidelines. 2020th ed. Arnhem: European Association of Urology Guidelines Office; 2020. p. 2020.

  38. Leijte JA, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161–8. https://doi.org/10.1016/j.eururo.2008.04.016.

    Article  PubMed  Google Scholar 

  39. Joshi SS, Handorf E, Strauss D, Correa AF, Kutikov A, Chen DYT, et al. Treatment trends and outcomes for patients with lymph node-positive cancer of the penis. JAMA Oncol. 2018;4(5):643–9. https://doi.org/10.1001/jamaoncol.2017.5608.

  40. Chipollini J, Necchi A, Spiess PE. Outcomes for patients with node-positive penile cancer: impact of perioperative systemic therapies and the importance of surgical intervention. Eur Urol. 2018;74(2):241–2. https://doi.org/10.1016/j.eururo.2018.04.025.

    Article  PubMed  Google Scholar 

  41. Canter DJ, Nicholson S, Watkin N, Hall E, Pettaway C. The international penile advanced cancer trial (InPACT): rationale and current status. Eur Urol Focus. 2019;5(5):706–9. https://doi.org/10.1016/j.euf.2019.05.010.

    Article  PubMed  Google Scholar 

  42. Delaunay B, Soh PN, Delannes M, Riou O, Malavaud B, Moreno F, et al. Brachytherapy for penile cancer: efficacy and impact on sexual function. Brachytherapy. 2014;13(4):380–7. https://doi.org/10.1016/j.brachy.2013.06.001.

  43. Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK. Quality of life for patients treated for penile cancer. J Urol. 2014;192(4):1105–10. https://doi.org/10.1016/j.juro.2014.04.014.

    Article  PubMed  Google Scholar 

  44. Romero FR, Romero KR, Mattos MA, Garcia CR, Fernandes Rde C, Perez MD. Sexual function after partial penectomy for penile cancer. Urology. 2005;66(6):1292–5. https://doi.org/10.1016/j.urology.2005.06.081.

    Article  PubMed  Google Scholar 

  45. Sansalone S, Silvani M, Leonardi R, Vespasiani G, Iacovelli V. Sexual outcomes after partial penectomy for penile cancer: results from a multi-institutional study. Asian J Androl. 2017;19(1):57–61. https://doi.org/10.4103/1008-682x.168690.

    Article  PubMed  Google Scholar 

  46. Sosnowski R, Kulpa M, Kosowicz M, Wolski JK, Kuczkiewicz O, Moskal K, et al. Quality of life in penile carcinoma patients - post-total penectomy. Cent European J Urol. 2016;69(2):204–11. https://doi.org/10.5173/ceju.2016.828.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Witty K, Branney P, Evans J, Bullen K, White A, Eardley I. The impact of surgical treatment for penile cancer – patients’ perspectives. Eur J Oncol Nurs. 2013;17(5):661–7. https://doi.org/10.1016/j.ejon.2013.06.004.

    Article  PubMed  Google Scholar 

  48. Sosnowski R, Wolski JK, Zi Talewicz U, Szyma Ski M, Baku AR, Demkow T. Assessment of selected quality of life domains in patients who have undergone conservative or radical surgical treatment for penile cancer: an observational study. Sex Health. 2019;16(1):32–8. https://doi.org/10.1071/sh17119.

    Article  PubMed  Google Scholar 

  49. Sedigh O, Falcone M, Ceruti C, Timpano M, Preto M, Oderda M, et al. Sexual function after surgical treatment for penile cancer: which organ-sparing approach gives the best results? Can Urol Assoc J. 2015;9(7–8):E423–7. https://doi.org/10.5489/cuaj.2801.

  50. Yang J, Chen J, Wu XF, Song NJ, Xu XY, Li Q, et al. Glans preservation contributes to postoperative restoration of male sexual function: a multicenter clinical study of glans preserving surgery. J Urol. 2014;192(5):1410–7. https://doi.org/10.1016/j.juro.2014.04.083.

  51. de Crevoisier R, Slimane K, Sanfilippo N, Bossi A, Albano M, Dumas I, et al. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys. 2009;74(4):1150–6. https://doi.org/10.1016/j.ijrobp.2008.09.054.

  52. Myers JB, Porten SP, McAninch JW. The outcomes of perineal urethrostomy with preservation of the dorsal urethral plate and urethral blood supply. Urology. 2011;77(5):1223–7. https://doi.org/10.1016/j.urology.2010.10.041.

    Article  PubMed  Google Scholar 

  53. Cappelleri JC, Rosen RC. The sexual health inventory for men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005;17(4):307–19. https://doi.org/10.1038/sj.ijir.3901327.

    Article  CAS  PubMed  Google Scholar 

  54. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–30. https://doi.org/10.1016/s0090-4295(97)00238-0.

    Article  CAS  PubMed  Google Scholar 

  55. Weinfurt KP, Lin L, Bruner DW, Cyranowski JM, Dombeck CB, Hahn EA, et al. Development and initial validation of the PROMIS(®) sexual function and satisfaction measures version 2.0. J Sex Med. 2015;12(9):1961–74. https://doi.org/10.1111/jsm.12966.

  56. Reeve BB, Wang M, Weinfurt K, Flynn KE, Usinger DS, Chen RC. Psychometric evaluation of PROMIS sexual function and satisfaction measures in a longitudinal population-based cohort of men with localized prostate cancer. J Sex Med. 2018;15(12):1792–810. https://doi.org/10.1016/j.jsxm.2018.09.015.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, et al. Sexual rehabilitation after treatment for prostate cancer-part 2: recommendations from the fourth international consultation for sexual medicine (ICSM 2015). J Sex Med. 2017;14(3):297–315. https://doi.org/10.1016/j.jsxm.2016.11.324.

    Article  PubMed  Google Scholar 

  58. Voznesensky M, Annam K, Kreder KJ. Understanding and managing erectile dysfunction in patients treated for cancer. J Oncol Pract. 2016;12(4):297–304. https://doi.org/10.1200/JOP.2016.010678.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Garaffa G, Raheem AA, Christopher NA, Ralph DJ. Total phallic reconstruction after penile amputation for carcinoma. BJU Int. 2009;104(6):852–6. https://doi.org/10.1111/j.1464-410X.2009.08424.x.

    Article  PubMed  Google Scholar 

  60. Burnett AL. Penile preserving and reconstructive surgery in the management of penile cancer. Nat Rev Urol. 2016;13(5):249–57. https://doi.org/10.1038/nrurol.2016.54.

    Article  PubMed  Google Scholar 

  61. Bickell M, Beilan J, Wallen J, Wiegand L, Carrion R. Advances in surgical reconstructive techniques in the management of penile, urethral, and scrotal cancer. Urol Clin North Am. 2016;43(4):545–59. https://doi.org/10.1016/j.ucl.2016.06.015.

    Article  PubMed  Google Scholar 

  62. Monstrey S, Hoebeke P, Selvaggi G, Ceulemans P, Van Landuyt K, Blondeel P, et al. Penile reconstruction: is the radial forearm flap really the standard technique? Plast Reconstr Surg. 2009;124(2):510–8. https://doi.org/10.1097/PRS.0b013e3181aeeb06.

    Article  CAS  PubMed  Google Scholar 

  63. Chang TS, Hwang WY. Forearm flap in one-stage reconstruction of the penis. Plast Reconstr Surg. 1984;74(2):251–8. https://doi.org/10.1097/00006534-198408000-00014.

    Article  CAS  PubMed  Google Scholar 

  64. Song R, Gao Y, Song Y, Yu Y, Song Y. The forearm flap. Clin Plast Surg. 1982;9(1):21–6.

    Article  CAS  PubMed  Google Scholar 

  65. Vriens JP, Acosta R, Soutar DS, Webster MH. Recovery of sensation in the radial forearm free flap in oral reconstruction. Plast Reconstr Surg. 1996;98(4):649–56. https://doi.org/10.1097/00006534-199609001-00008.

    Article  CAS  PubMed  Google Scholar 

  66. Perovic SV, Djinovic R, Bumbasirevic M, Djordjevic M, Vukovic P. Total phalloplasty using a musculocutaneous latissimus dorsi flap. BJU Int. 2007;100(4):899–905; discussion. https://doi.org/10.1111/j.1464-410X.2007.07084.x.

    Article  PubMed  Google Scholar 

  67. Jun MS, Pušica S, Kojovic V, Bizic M, Stojanovic B, Krstic Z, et al. Total phalloplasty with latissimus dorsi musculocutaneous flap in female-to-male transgender surgery. Urology. 2018;120:269–70. https://doi.org/10.1016/j.urology.2018.06.032.

  68. Djordjevic ML, Bencic M, Kojovic V, Stojanovic B, Bizic M, Kojic S, et al. Musculocutaneous latissimus dorsi flap for phalloplasty in female to male gender affirmation surgery. World J Urol. 2019;37(4):631–7. https://doi.org/10.1007/s00345-019-02641-w.

  69. Sadove RC, Sengezer M, McRoberts JW, Wells MD. One-stage total penile reconstruction with a free sensate osteocutaneous fibula flap. Plast Reconstr Surg. 1993;92(7):1314–23 discussion 24-5.

    CAS  PubMed  Google Scholar 

  70. Sengezer M, Oztürk S, Deveci M, Odabaşi Z. Long-term follow-up of total penile reconstruction with sensate osteocutaneous free fibula flap in 18 biological male patients. Plast Reconstr Surg. 2004;114(2):439–50; discussion 51-2. https://doi.org/10.1097/01.prs.0000131883.27191.86.

    Article  PubMed  Google Scholar 

  71. Zuckerman JM, Smentkowski K, Gilbert D, Storme O, Jordan G, Virasoro R, et al. Penile prosthesis implantation in patients with a history of total phallic construction. J Sex Med. 2015;12(12):2485–91. https://doi.org/10.1111/jsm.13067.

  72. Falcone M, Garaffa G, Gillo A, Dente D, Christopher AN, Ralph DJ. Outcomes of inflatable penile prosthesis insertion in 247 patients completing female to male gender reassignment surgery. BJU Int. 2018;121(1):139–44. https://doi.org/10.1111/bju.14027.

    Article  CAS  PubMed  Google Scholar 

  73. Neuville P, Morel-Journel N, Maucourt-Boulch D, Ruffion A, Paparel P, Terrier JE. Surgical outcomes of erectile implants after phalloplasty: retrospective analysis of 95 procedures. J Sex Med. 2016;13(11):1758–64. https://doi.org/10.1016/j.jsxm.2016.09.013.

    Article  PubMed  Google Scholar 

  74. •• Neuville P, Morel-Journel N, Cabelguenne D, Ruffion A, Paparel P, Terrier JE. First outcomes of the ZSI 475 FtM, a specific prosthesis designed for phalloplasty. J Sex Med. 2019;16(2):316–22. https://doi.org/10.1016/j.jsxm.2018.11.013This article provides the initial outcomes of phalloplasty patients receiving a ZSI 475 FtM inflatable penile prosthesis.

    Article  PubMed  Google Scholar 

  75. •• GLS P, Sigurjónsson H, Ronkes B, Al-Tamimi M, van der Sluis WB. Surgical experience and outcomes of implantation of the ZSI 100 FtM malleable penile implant in transgender men after phalloplasty. J Sex Med. 2020;17(1):152–8. https://doi.org/10.1016/j.jsxm.2019.09.019This article is important because it provides the initial outcomes of phalloplasty patients receiving a ZSI 100 FtM malleable penile prosthesis.

    Article  Google Scholar 

  76. Donnellan SM, Webb DR. Management of invasive penile cancer by synchronous penile lengthening and radical tumour excision to avoid perineal urethrostomy. The Australian and New Zealand journal of surgery. 1998;68(5):369–70. https://doi.org/10.1111/j.1445-2197.1998.tb04775.x.

    Article  CAS  PubMed  Google Scholar 

  77. Caso J, Keating M, Miranda-Sousa A, Carrion R. Ventral phalloplasty. Asian J Androl. 2008;10(1):155–7. https://doi.org/10.1111/j.1745-7262.2008.00365.x.

    Article  PubMed  Google Scholar 

  78. Miranda-Sousa A, Keating M, Moreira S, Baker M, Carrion R. Concomitant ventral phalloplasty during penile implant surgery: a novel procedure that optimizes patient satisfaction and their perception of phallic length after penile implant surgery. J Sex Med. 2007;4(5):1494–9. https://doi.org/10.1111/j.1743-6109.2007.00551.x.

    Article  PubMed  Google Scholar 

  79. •• Wallen JJ, Baumgarten AS, Kim T, Hakky TS, Carrion RE, Spiess PE. Optimizing penile length in patients undergoing partial penectomy for penile cancer: novel application of the ventral phalloplasty oncoplastic technique. Int Braz J Urol. 2014;40(5):708–9. https://doi.org/10.1590/s1677-5538.Ibju.2014.05.18This article presents a video detailing a novel manner in which to improve cosmesis and perceived penile length of patients undergoing partial penectomy.

    Article  PubMed  Google Scholar 

  80. Hage JJ. Simple, safe, and satisfactory secondary penile enhancement after near-total oncologic amputation. Ann Plast Surg. 2009;62(6):685–9. https://doi.org/10.1097/SAP.0b013e3181835ae1.

    Article  CAS  PubMed  Google Scholar 

  81. Podlasek CA, Mulhall J, Davies K, Wingard CJ, Hannan JL, Bivalacqua TJ, et al. Translational perspective on the role of testosterone in sexual function and dysfunction. J Sex Med. 2016;13(8):1183–98. https://doi.org/10.1016/j.jsxm.2016.06.004.

  82. Opjordsmoen S, Fossa SD. Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol. 1994;74(5):652–7. https://doi.org/10.1111/j.1464-410x.1994.tb09200.x.

    Article  CAS  PubMed  Google Scholar 

  83. Ficarra V, Righetti R, D'Amico A, Pilloni S, Balzarro M, Schiavone D, et al. General state of health and psychological well-being in patients after surgery for urological malignant neoplasms. Urol Int. 2000;65(3):130–4. https://doi.org/10.1159/000064857.

    Article  CAS  PubMed  Google Scholar 

  84. • Gordon H, LoBiondo-Wood G, Malecha A. Penis cancer: the lived experience. Cancer Nurs. 2017;40(2):E30-e8. https://doi.org/10.1097/ncc.0000000000000366This article is important because it provides insight into the psychological factors that affect men diagnosed with penile cancer and undergoing treatment.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of South Florida-Morsani College of Medicine, 12901 Bruce B Downs Blvd, Tampa, FL, 33612, USA

    George Coba

  2. Department of Urology, University of South Florida Morsani College of Medicine, 2 Tampa General Circle, STC6, Tampa, FL, 33606, USA

    Trushar Patel

Authors
  1. George Coba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Trushar Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Trushar Patel.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Financial Disclosure

Dr. Patel and Mr. Coba have nothing to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Men's Health

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coba, G., Patel, T. Penile Cancer: Managing Sexual Dysfunction and Improving Quality of Life After Therapy. Curr Urol Rep 22, 8 (2021). https://doi.org/10.1007/s11934-020-01022-w

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11934-020-01022-w

Keywords

Search

Navigation